Meklēšana Attēli Maps Play YouTube Ziņas Gmail Disks Vēl »
Ieiet
Grāmatas Grāmatas
" ProHance* should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. "
Code of Federal Regulations: Containing a Codification of Documents of ... - 18. lappuse
2000
Pilnskats - Par šo grāmatu

The Code of Federal Regulations of the United States of America

1989 - 240 lapas
...been shown to be teratogenic (or to have an embryocidal effect or other adverse effect) in (.ñaméis) of species) when given in doses (x) times the human...fetus." The labeling shall contain a description of the a.nimn.1 studies. If there are no animal reproduction studies and no adequate and well-controlled studies...
Pilnskats - Par šo grāmatu

Oversight on Efforts to Reduce Infant Mortality and to Improve Pregnancy ...

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Child and Human Development - 1981 - 716 lapas
...(x) times the human dose. There are no adequate and wellcontrolled studies in pregnant women. (Nome of drug] should be used during pregnancy only if the...studies and no adequate and well-controlled studies in humant, the labeling shall state: "Pregnancy Category C. Animal reproduction studies have not been...
Pilnskats - Par šo grāmatu

In the Heart of the Village: The World of the Indian Banyan Tree

Barbara Bash - 2002 - 234 lapas
...human exposure based on the AUCo-24 at 200 mg BID). There are no studies in pregnant women. CELEBREX should be used during pregnancy only if the potential benefit justifies the potential risk to the ; etus. Nonteratogenic effects: Celecoxib produced preimplantation and post-implantation losses and...
Ierobežota priekšskatīšana - Par šo grāmatu

Cardiac Problems in Pregnancy: Diagnosis and Management of Maternal and ...

Uri Elkayam, Norbert Gleicher - 1998 - 1110 lapas
.... [On pregnancy:] There are no adequate and well controlled studies in pregnant women. Cyclosporine should be used during pregnancy only if the potential...benefit justifies the potential risk to the fetus. Azathioprine Azathioprine is an imidazole derivative of 6-mercaptopurine. Its active metabolites cross...
Ierobežota priekšskatīšana - Par šo grāmatu

Psychologists' Psychotropic Drug Reference

Louis A. Pagliaro, Ann M. Pagliaro - 1999 - 732 lapas
...and the embryo, fetus, or neonate (see Opiate Analgesics General Monograph). Prescribe buprenorphine during pregnancy only if the potential benefit justifies the potential risk to the embryo, fetus, or neonate. Collaboration with the patient's obstetrician is indicated. Women who are...
Ierobežota priekšskatīšana - Par šo grāmatu

European Blue List: European Drug Registrations. Grundwerk

Karl Feiden - 1999 - 670 lapas
...pregnancy Crixivan has not been studied in pregnant women. Until additional data become available, Crixivan should be used during pregnancy only if the potential...benefit justifies the potential risk to the fetus. Hyperbilirubinaemia, reported predominantly as elevated indirect bilirubin, has occured in 10% of patients...
Ierobežota priekšskatīšana - Par šo grāmatu

Quality Assurance/quality Improvement

572 lapas
...Pregnancy and lactation: • Corticosteroids are classified in FDA pregnancy category C and should be given only if the potential benefit justifies the potential risk to the fetus • Fetal adrenal hypoplasia may occur with large doses of corticosteroids for prolonged periods during...
Ierobežota priekšskatīšana - Par šo grāmatu

Principles and Practice of Travel Medicine

Dr. Jane N. Zuckerman - 2002 - 520 lapas
...humans, or animal studies are either positive for fetal risk or lacking as well. Drugs should be given only if the potential benefit justifies the potential risk to the fetus There is positive evidence of human fetal risk. Nevertheless, potential benefits may outweigh the potential...
Ierobežota priekšskatīšana - Par šo grāmatu

Women and Cannabis: Medicine, Science, and Sociology

Ethan Russo, Melanie Creagan Dreher, Mary Lynn Mathre - 2002 - 208 lapas
...to the fetus with no controlled human studies). The drug labeling states that Marinol should be used only if the potential benefit justifies the potential risk to the fetus. Likewise, its use in nursing mothers is not recommended since Marinol is concentrated in and secreted...
Ierobežota priekšskatīšana - Par šo grāmatu

Modern Pharmacology with Clinical Applications

Charles R. Craig, Robert E. Stitzel - 2004 - 878 lapas
...reaction to salicylates or any other NSAID. Asthmatics are at particular risk for these reactions. NSAIDs should be used during pregnancy only if the potential benefit justifies the risk to the fetus. A significant number of drug interactions are common to most of the NSAIDs. The...
Ierobežota priekšskatīšana - Par šo grāmatu




  1. Mana bibliotēka
  2. Palīdzība
  3. Izvērstā grāmatu meklēšana
  4. Lejupielādējiet ePub
  5. Lejupielādēt PDF